Demand Continues to Out Pace Supply of H1N1 Vaccine

WASHINGTON -- Chances are you know someone who's come down with the high fever and aches and pains typical of the swine flu.

H1N1 cases are now widespread in 48 states, and it continues to be a young people's disease.

Doses of the vaccine are coming off production lines at a furious pace, almost as quickly as people line up to get it.

Vaccine manufacturer Sanofi Pasteur expects to make 75 million doses this year.

"We've been working 24/7 over past several months to prepare and get as much vaccine out as fast as we can," says Sanofi's Dr. Sam Lee.

The Centers for Disease Control reports it now has 38 million doses of the vaccine available, twice as much as it had two weeks ago.

Despite the increase a new Harvard poll shows about half of people trying to find the vaccine can not.

There was a public backlash this week when it was learned New York City financial firms got the H1N1 vaccine ahead of some hospitals, but the CDC says it doesn't really matter where people are getting the vaccine as long as the right people are getting it.

They also say there is no evidence the firms gave the vaccine to anyone other than people most at risk for H1N1 complications, like pregnant women and people with underlying health conditions.

Meanwhile, there are 159 million Americans in those high priority groups hoping the vaccine gets to them before the flu does.